How Japan’s ‘trusted web’ could improve digital governance World Economic Forum
Source: news.google.com – Read more

Novartis Nabs FDA Approval for First-of-Its-Kind Drug for Chronic Hives
Novartis drug Rhapsido is now approved as a second-line treatment for chronic spontaneous urticaria, a rare inflammatory skin disease. Additional clinical trials are ongoing to